SyntheticMR
SyntheticMR receives FDA 510(k) clearance for SyMRI 15
SyMRI 15 offers an innovative approach to MRI, transforming traditional imaging methodologies with its advanced synthetic imaging technology. Clinically validated through extensive multi-center studies across leading institutions in the United States, SyMRI 15 has proven its capability to enhance imaging workflows by replacing conventional 3D imaging techniques in addition to its unique ability to provide tissue quantification. This technology offers significant gains in both efficiency and throughput while maintaining the highest standards of diagnostic accuracy.
| Datum | 2024-12-06, kl 20:44 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!